Literature DB >> 22814467

A swordless knight: epidemiology and molecular characteristics of the blaKPC-negative sequence type 258 Klebsiella pneumoniae clone.

Amos Adler1, Svetlana Paikin, Yelena Sterlin, Josef Glick, Rotem Edgar, Rima Aronov, Mitchell J Schwaber, Yehuda Carmeli.   

Abstract

In June 2010, a bla(KPC)-negative, ertapenem-resistant ST-258 Klebsiella pneumoniae strain was isolated from a patient in the Laniado Medical Center (LMC). Our aims were (i) to describe its molecular characteristics and resistance mechanisms and (ii) to assess whether the bla(KPC)-negative ST-258 K. pneumoniae clone spreads as efficiently as its KPC-producing isogenic strain. In a prospective study, surveillance of all ertapenem-resistant, carbapenemase-negative K. pneumoniae (ERCNKP) isolates was conducted from June 2010 to May 2011 at LMC (314 beds) and from July 2008 to December 2010 at the Tel Aviv Sourasky Medical Center (TASMC) (1,200 beds). Molecular typing was done by arbitrarily primed PCR, pulsed-field gel electrophoresis (PFGE), and multilocus sequence typing (MLST). A total of 8 of 42 (19%) ERCNKP isolates in LMC and 1 of 32 (3.1%) in TASMC belonged to the ST-258 clone. These strains carried the bla(CTX-M-2) or the bla(CTX-M-25) extended-spectrum β-lactamase (ESBL) gene. Sequencing of the ompK genes showed a frameshift mutation in the ompK35 gene. The fate of the bla(KPC)-carrying plasmid, pKpQIL, was determined by S1 analysis and by PCR of the Tn4401 transposon, repA, and the truncated bla(OXA-9). Plasmid analysis of the ERCNKP ST-258 isolates showed variability in plasmid composition and absence of the Tn4401 transposon and the pKpQIL plasmid. In addition, the ST-258 clone was identified in 35/35 (100%) of KPC-producing K. pneumoniae isolates but in none of 62 ertapenem-susceptible K. pneumoniae isolates collected in the two centers. Our results suggest that ERCNKP ST-258 evolved by loss of the bla(KPC)-carrying plasmid pKpQIL. ERCNKP ST-258 appears to have low epidemic potential.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22814467      PMCID: PMC3457422          DOI: 10.1128/JCM.00987-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  47 in total

1.  Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center.

Authors:  Neil Woodford; Philip M Tierno; Katherine Young; Luke Tysall; Marie-France I Palepou; Elaina Ward; Ronald E Painter; Deborah F Suber; Daniel Shungu; Lynn L Silver; Kenneth Inglima; John Kornblum; David M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

2.  Extended-spectrum beta-lactamases among Enterobacter isolates obtained in Tel Aviv, Israel.

Authors:  Jacob Schlesinger; Shiri Navon-Venezia; Inna Chmelnitsky; Orly Hammer-Münz; Azita Leavitt; Howard S Gold; Mitchell J Schwaber; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

3.  Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum (beta)-lactamases.

Authors:  Neil Woodford; Elizabeth J Fagan; Matthew J Ellington
Journal:  J Antimicrob Chemother       Date:  2005-11-10       Impact factor: 5.790

4.  Molecular epidemiology of an outbreak due to extended-spectrum beta-lactamase-producing enterobacteria in a French hospital.

Authors:  H Bermudes; C Arpin; F Jude; Z el-Harrif; C Bébéar; C Quentin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-07       Impact factor: 3.267

5.  Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates.

Authors:  Laure Diancourt; Virginie Passet; Jan Verhoef; Patrick A D Grimont; Sylvain Brisse
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

6.  CTX-M-2 and a new CTX-M-39 enzyme are the major extended-spectrum beta-lactamases in multiple Escherichia coli clones isolated in Tel Aviv, Israel.

Authors:  Inna Chmelnitsky; Yehuda Carmeli; Azita Leavitt; Mitchell J Schwaber; Shiri Navon-Venezia
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

7.  Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae.

Authors:  H Yigit; A M Queenan; G J Anderson; A Domenech-Sanchez; J W Biddle; C D Steward; S Alberti; K Bush; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

8.  Identification of plasmids by PCR-based replicon typing.

Authors:  Alessandra Carattoli; Alessia Bertini; Laura Villa; Vincenzo Falbo; Katie L Hopkins; E John Threlfall
Journal:  J Microbiol Methods       Date:  2005-06-02       Impact factor: 2.363

9.  High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla(ACT-1) beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoe.

Authors:  Frank M Kaczmarek; Fadia Dib-Hajj; Wenchi Shang; Thomas D Gootz
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

10.  Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae.

Authors:  Laurent Poirel; Claire Héritier; Venus Tolün; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

View more
  14 in total

Review 1.  The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae.

Authors:  Amy J Mathers; Gisele Peirano; Johann D D Pitout
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

Review 2.  Clinical Implications of Genomic Adaptation and Evolution of Carbapenem-Resistant Klebsiella pneumoniae.

Authors:  Angela Gomez-Simmonds; Anne-Catrin Uhlemann
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

Review 3.  Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance.

Authors:  Johann D D Pitout; Patrice Nordmann; Laurent Poirel
Journal:  Antimicrob Agents Chemother       Date:  2015-07-13       Impact factor: 5.191

4.  Effect of Resistance Mechanisms on the Inoculum Effect of Carbapenem in Klebsiella pneumoniae Isolates with Borderline Carbapenem Resistance.

Authors:  Amos Adler; Ma'ayan Ben-Dalak; Ina Chmelnitsky; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2015-05-18       Impact factor: 5.191

5.  An Analysis of the Epidemic of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Convergence of Two Evolutionary Mechanisms Creates the "Perfect Storm".

Authors:  Laura J Rojas; George M Weinstock; Elsa De La Cadena; Lorena Diaz; Rafael Rios; Blake M Hanson; Joseph S Brown; Purva Vats; Daniel S Phillips; Hoan Nguyen; Kristine M Hujer; Adriana Correa; Mark D Adams; Federico Perez; Erica Sodergren; Apurva Narechania; Paul J Planet; Maria V Villegas; Robert A Bonomo; Cesar A Arias
Journal:  J Infect Dis       Date:  2017-12-27       Impact factor: 5.226

6.  Genomic Analysis of the Emergence and Rapid Global Dissemination of the Clonal Group 258 Klebsiella pneumoniae Pandemic.

Authors:  Jolene R Bowers; Brandon Kitchel; Elizabeth M Driebe; Duncan R MacCannell; Chandler Roe; Darrin Lemmer; Tom de Man; J Kamile Rasheed; David M Engelthaler; Paul Keim; Brandi M Limbago
Journal:  PLoS One       Date:  2015-07-21       Impact factor: 3.240

Review 7.  Epidemiology of carbapenemase-producing Enterobacteriaceae and Acinetobacter baumannii in Mediterranean countries.

Authors:  Nassima Djahmi; Catherine Dunyach-Remy; Alix Pantel; Mazouz Dekhil; Albert Sotto; Jean-Philippe Lavigne
Journal:  Biomed Res Int       Date:  2014-05-13       Impact factor: 3.411

8.  Complete Genome Sequence of KPC-3- and CTX-M-15-Producing Klebsiella pneumoniae Sequence Type 307.

Authors:  Laura Villa; Claudia Feudi; Daniela Fortini; Michele Iacono; Celestino Bonura; Andrea Endimiani; Caterina Mammina; Alessandra Carattoli
Journal:  Genome Announc       Date:  2016-04-07

9.  An Outbreak of Carbapenem-Resistant Klebsiella pneumoniae in an Intensive Care Unit of a Major Teaching Hospital in Chongqing, China.

Authors:  Lingyi Zeng; Chengru Yang; Jisheng Zhang; Kewang Hu; Jingbo Zou; Jie Li; Jianmin Wang; Wan Huang; Lining Yin; Xiaoli Zhang
Journal:  Front Cell Infect Microbiol       Date:  2021-06-02       Impact factor: 5.293

10.  Detection of new SHV-12, SHV-5 and SHV-2a variants of extended spectrum beta-lactamase in Klebsiella pneumoniae in Egypt.

Authors:  Enas A Newire; Salwa F Ahmed; Brent House; Esmeralda Valiente; Guillermo Pimentel
Journal:  Ann Clin Microbiol Antimicrob       Date:  2013-07-18       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.